Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2010

Dec 21, 2010

30291_dirs_2010-12-21_e088976c-a87d-4cb4-8aeb-959074abe70d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-12-17

Reporting Person: SCHNEIER CRAIG ERIC (EVP, HR, Public Affairs & Comm)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-12-17 Common Stock M 19450 $49.31 Acquired 40566.2794 Direct
2010-12-17 Common Stock S 19450 $68.20 Disposed 21116.2794 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-12-17 Stock Option (Right to Buy) $49.31 M 19450 Disposed 2017-02-11 Common Stock (19450) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 460 Indirect

Footnotes

F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).

F3: The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.